The value of postoperative radiotherapy in renal cell carcinoma: A single-institution experience

Tumori

Volumn 92, Issue 3, 2006, Pages 202-206

  Ulutin, H Cuneyt ^a,b   Aksu, Gorkem ^a   Fayda, Merdan ^a   Kuzhan, Okhan ^a   Tahmaz, Lutfu ^a   Beyzadeoglu, Murat ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

Radiotherapy; Renal cell carcinoma

Indexed keywords

LACTATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; IRRADIATION; KIDNEY CARCINOMA; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; METASTASIS; MULTIVARIATE ANALYSIS; NEPHRECTOMY; POSTOPERATIVE CARE; PROGNOSIS; RADIATION DOSE; RADIATION FIELD; SURVIVAL RATE; TUMOR VOLUME; UNIVARIATE ANALYSIS;

EID: 33746267280     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160609200303     Document Type: Article

References (15)

1. Muscat JE, Hoffmann D, Wynder EL: The epidemiology of renal cell carcinoma. A second look. Cancer, 75: 2552-2557, 1995.
2. Kao GD, Malkowicz SB, Whittington R, D'Amico AV, Wein AJ: Locally advanced renal cell carcinoma: Low complication rate and efficiency of postnephrectomy radiation therapy planned with CT. Radiology, 193: 725-730, 1994.
3. Flocks RH, Kadesky MC: Malignant neoplasms of the kidney: An analysis of 353 patients followed for five years or more. J Urol, 79: 196, 1958.
4. Rafla S: Renal cell carcinoma. Cancer, 25: 26-40, 1970.
5. Rafla S, Parikh K: The role of adjuvant radiotherapy in the management of renal cell carcinoma. In: Cancer of the kidney, Javadpour N (Ed), p 231, Thieme-Stratton, New-York, 1984.
6. Stein M, Kuten A, Halpern J, Coachman NM, Cohen Y, Robinson E: The value of postoperative irradiation in renal cancer. Radiother Oncol, 24: 41-44, 1992.
7. Newmark JR, Newmark GM, Epstein JI, Marshall FF: Solitary late recurrence of renal cell carcinoma. Urology, 43: 725-728, 1994.
8. Lai PP: Kidney, renal pelvis and ureter. In: Principles and practice of radiation oncology, Perez CA, Brady LW (Eds), p 1032, JB Lippincott, Philadelphia, 1992.
9. Makarewicz R, Zarzycka M, Kulinska G, Windorbska W: The value of postoperative radiotherapy in advanced renal cell cancer. Neoplasm, 45: 380-383, 1998.
10. Eilenberger M, Kodym R, Seyss R: A retrospective study of the results of postoperative radiotherapy in hypernephroma. Radiobiol Radiother, 31: 491-496, 1990.
11. Scherer E, Wirtz C: The role of postoperative radiotherapy in the treatment of hypernephroid carcinoma. Strahlenther Oncol, 164: 371-385, 1988.
12. Gez E, Libes M, Bar-Deroma R, Rubinov R, Stein M, Kuten A: Postoperative irradiation in localized renal cell carcinoma: The Rambam Medical Center experience. Tumori, 88: 500-502, 2002.
13. Finney R: An evalution of postoperative radiotherapy in hypernephroma treatment - a clinical trial. Cancer, 32: 1332-1340, 1973.
14. Kjaer M, Frederiksen PL, Engelholm SA: Postoperative radiotherapy in stage II and III renal adenocarcinoma: A randomized trial by the Copenhagen Renal Cancer study group. Int J Radiat Oncol Biol Phys, 13: 665-672, 1987.
15. Rabinovitch RA, Zelefsky MJ, Gaynor JJ, Fuks Z: Patterns of failure following surgical resection of renal cell carcinoma: Implications for adjuvant and local systemic therapy. J Clin Oncol, 12: 206-212, 1994.